News & Events

Vorige week werden de resultaten van de verschillende onderzoeksthema’s binnen het deelprogramma Regulatoire Pandemische Paraatheid gepresenteerd op het ministerie van Volksgezondheid, Welzijn en

Vandaag zijn tijdens een bijeenkomst op het ministerie van Volksgezondheid, Welzijn en Sport (VWS) de resultaten van de verschillende onderzoeksthema’s binnen het deelprogramma Regulatoire Pandemische Paraatheid gepresenteerd. Bij de presentatie waren vertegenwoordigers van ZonMw, het Ministerie van VWS, FAST, RSNN en andere betrokkenen aanwezig.

On 23 May 2023, the Regulatory Science Network Netherlands (RSNN) organized an expert meeting  on the topic of: 'Facilitating human relevant safety assessment of medicinal products: towards implementation of new approach methodologies (NAMs)’.

On 4 April 2023, the Regulatory Science Network Netherlands (RSNN) organized an expert meeting on the topic of ‘Direct Healthcare Professional Communication: Recommendations to improve impact’.  The full report of the Expert Meeting is available now.

During the upcoming FIGON Dutch Medicines days on 20 and 21 September, the RSNN will organize a session about pandemic preparedness in the context of regulation.

The full report of the RSNN Annual Workshop titled "Pharmaceutical regulation - Highway to innovation” which took place on 6 June 2023 is now available.

On 6 June the RSNN Special Interest Group Advanced Therapies organized its workshop and networking event. We are looking back at a successful morning with great interaction.

On 6 June the RSNN organized its Annual Workshop. We are looking back at a successful afternoon with great interaction, inspiring speakers and insights from various stakeholder groups (patients, industry, academia, and regulators) on the topic of "pharmaceutical regulation - highway to innovation".

Are you interested in and capable of conducting and developing methodological and applied research at a high international level in the field of Drug Regulatory Science? Then apply for the role as an Assistant Professor in Drug Regulatory Science with a special focus on future medicine at Utrecht University.

On 25 October 2022 the RSNN organized an RSNN Expert Meeting on “Regulator-initiated studies for regulatory decision-making”. The full report of this Expert Meeting is available now. 

A new edition of the RSNN Newsletter has just been published.

The full report of the RSNN Annual Workshop titled "Patient preferences: towards a more structural incorporation in the regulatory pathway" which took place on 5 September 2022 is now available.

On 25 November Professor and Regulatory Science Network Netherlands co-chair Peter Mol will deliver his inaugural lecture titled: 'Drug Regulatory Science, collaborate to improve drug development and evaluation' at the Academy Building of the University of Groningen.

A new edition of the RSNN Newsletter has just been published.

Both the Centre for Future Affordable and Sustainable Therapy development (FAST) and the Regulatory Science Network Netherlands (RSNN) aim to advance and innovate the regulatory system, to ultimately improve the development, accessibility, and appropriate use of therapies for patients.